Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 675 of 3284 entries
View as:

AZD5305 hADME in Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06713369 Org: User:
Start: 04/02/25 End: 09/10/26 Due: 09/10/27

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Phase: N/A Priority: Normal
NCT ID: NCT06749457 Org: User:
Start: 12/30/24 End: 07/06/27 Due: 07/06/28

A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00382239 Org: User:
Start: 09/30/06 End: 05/31/07 Due: 05/31/08

Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users

Phase: N/A Priority: Normal
NCT ID: NCT06659029 Org: User:
Start: 08/29/25 End: 04/15/31 Due: 04/15/32

A Study to Investigate How AZD4144 Affects the Pharmacokinetics of Rosuvastatin in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06925854 Org: User:
Start: 04/17/25 End: 06/12/25 Due: 06/12/26

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00516048 Org: User:
Start: 08/31/07 End: 04/30/08 Due: 04/30/09

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05774951 Org: User:
Start: 03/31/23 End: 05/29/36 Due: 05/29/37

Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients

Phase: N/A Priority: Normal
NCT ID: NCT00921804 Org: User:
Start: 06/30/09 End: 05/31/10 Due: 05/31/11

A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00240305 Org: User:
Start: 04/30/04 End: 05/31/06 Due: 05/31/07

Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01625286 Org: User:
Start: 10/03/12 End: 10/03/22 Due: 10/03/23

A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00585000 Org: User:
Start: 12/31/07 End: 01/31/10 Due: 01/31/11

A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy

Phase: N/A Priority: Normal
NCT ID: NCT01136655 Org: User:
Start: 09/30/10 End: 12/31/11 Due: 12/31/12

A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT06703658 Org: User:
Start: 11/02/24 End: 03/13/25 Due: 03/13/26

iCaReMe Global Registry

Phase: N/A Priority: Normal
NCT ID: NCT03549754 Org: User:
Start: 02/17/18 End: 12/31/25 Due: 12/31/26

A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06188520 Org: User:
Start: 12/05/23 End: 06/17/26 Due: 06/17/27

A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06554821 Org: User:
Start: 08/05/24 End: 10/08/24 Due: 10/08/25

Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04494425 Org: User:
Start: 07/24/20 End: 06/19/26 Due: 06/19/27

A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults

Phase: N/A Priority: Normal
NCT ID: NCT05437289 Org: User:
Start: 10/09/21 End: 01/16/23 Due: 01/16/24

Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT02121288 Org: User:
Start: 12/31/14 End: 02/29/16 Due: 02/28/17

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00321490 Org: User:
Start: 04/30/06 End: 05/31/07 Due: 05/31/08

Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)

Phase: N/A Priority: Normal
NCT ID: NCT00062582 Org: User:
Start: 06/30/03 End: - Due: -

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT00516724 Org: User:
Start: 06/22/07 End: 04/11/24 Due: 04/11/25

A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04214288 Org: User:
Start: 04/22/20 End: 04/13/26 Due: 04/13/27

Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice

Phase: N/A Priority: Normal
NCT ID: NCT02719132 Org: User:
Start: 07/31/16 End: 11/30/17 Due: 11/30/18

Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00856908 Org: User:
Start: 02/28/09 End: 08/31/09 Due: 08/31/10